Avançando na pesquisa sobre câncer pediátrico: atualizações da reunião do Cure Group 4
On January 29, 2025, MBI researchers joined the latest Cure Group 4 Consortium meeting, connecting experts from the US, Canada, and Germany. The team discussed preparations for two upcoming FDA-approved clinical trials and set new research goals. Dr. Gene Hwang, head of Oncology at Children’s National in Washington, D.C., highlighted the impact of these efforts, […]
Acelerando o progresso: financiando a esperança para o câncer cerebral infantil
Brain tumors are the leading cause of cancer-related deaths in children, with medulloblastoma relapsing in 30% of cases. Current treatments, developed in the 1980s, often cause severe, lifelong side effects—when survival is even possible. Now, hope is within reach. Three groundbreaking clinical trials are ready to launch, but $3 million is needed to fund and […]
